ImmunoCellular Therapeutics Ltd. (IMUC) Gained 5.72% or 0.01 To Price $0.26 On Wednesday


ImmunoCellular Therapeutics Ltd. (IMUC) gained 5.72% or 0.01 to $0.26. It is around 303030 shares traded, which is 63.48% compare to the average total volume 477339. The market cap of IMUC is $11.09 million. The year to date change is -21.41%. The 52 week price range is from $0.17 to $2.79. Price of IMUC have changed -1.84% during last week. It have changed -8.25% over last month, -3.88% over last 3 months, -19.32% over last 6 months and -72.21% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for IMUC is 0.26. The 200-day Moving Averages for IMUC is 0.30. It is 15.38% above current price. The 52-week High is 2.79. It is 973.08% from the current price. The 52-week Low is 0.17. It is -34.62% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of IMUC is 5.48 on 2018-05-31. Short % to float is 6.78%. There are some statistics of IMUC. It is has market cap $11.09 million. The share outstanding is 41.93 million. The average volume is 477339. The percent of top 15 Institution holding is 5.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of IMUC is -604.84%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of IMUC is -147.53%.


Tags:

Share this post